James R. Anson

447 total citations
13 papers, 366 citations indexed

About

James R. Anson is a scholar working on Epidemiology, Genetics and Virology. According to data from OpenAlex, James R. Anson has authored 13 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Genetics and 3 papers in Virology. Recurrent topics in James R. Anson's work include Cervical Cancer and HPV Research (11 papers), Virus-based gene therapy research (6 papers) and T-cell and Retrovirus Studies (3 papers). James R. Anson is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Virus-based gene therapy research (6 papers) and T-cell and Retrovirus Studies (3 papers). James R. Anson collaborates with scholars based in United States, Japan and Germany. James R. Anson's co-authors include Michael J. Lace, Thomas H. Haugen, Lubomír P. Turek, Gregory S. Thomas, Yasushi Yamakawa, Elaine Smith, Jens Peter Klußmann, Aloysius J. Klingelhutz, Takaoki Ishiji and Aaron Bossler and has published in prestigious journals such as Journal of Virology, Virology and Carcinogenesis.

In The Last Decade

James R. Anson

13 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Anson United States 10 273 114 80 76 74 13 366
Melissa C. Stoppler United States 7 327 1.2× 156 1.4× 49 0.6× 93 1.2× 82 1.1× 23 461
Elke Beyer‐Finkler Germany 6 242 0.9× 115 1.0× 48 0.6× 61 0.8× 63 0.9× 6 313
Jordan M. Meyers United States 8 243 0.9× 126 1.1× 60 0.8× 61 0.8× 86 1.2× 9 422
Meghan Hotz United States 3 364 1.3× 134 1.2× 22 0.3× 113 1.5× 115 1.6× 4 457
Tara J. Nulton United States 7 171 0.6× 123 1.1× 81 1.0× 35 0.5× 44 0.6× 7 326
Michaël Lehoux Canada 8 239 0.9× 155 1.4× 26 0.3× 56 0.7× 64 0.9× 10 365
Walter G. Hubert United States 6 311 1.1× 159 1.4× 29 0.4× 81 1.1× 67 0.9× 7 372
Louis Cicchini United States 9 329 1.2× 164 1.4× 53 0.7× 39 0.5× 159 2.1× 10 550
Valdimara Corrêa Vieira Brazil 7 143 0.5× 143 1.3× 55 0.7× 33 0.4× 74 1.0× 11 317
Heike E. Brand United States 9 123 0.5× 99 0.9× 30 0.4× 38 0.5× 141 1.9× 10 289

Countries citing papers authored by James R. Anson

Since Specialization
Citations

This map shows the geographic impact of James R. Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Anson more than expected).

Fields of papers citing papers by James R. Anson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Anson. The network helps show where James R. Anson may publish in the future.

Co-authorship network of co-authors of James R. Anson

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Anson. A scholar is included among the top collaborators of James R. Anson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Anson. James R. Anson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lace, Michael J., James R. Anson, Thomas H. Haugen, Jason M. Dierdorff, & Lubomír P. Turek. (2014). Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration. Carcinogenesis. 36(1). 151–159. 11 indexed citations
2.
Lace, Michael J., Lubomír P. Turek, James R. Anson, & Thomas H. Haugen. (2014). Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony‐Forming Assay. Current Protocols in Microbiology. 33(1). 14B.2.1–13. 5 indexed citations
3.
4.
Lace, Michael J., James R. Anson, Thomas H. Haugen, & Lubomír P. Turek. (2010). Interferon regulatory factor (IRF)-2 activates the HPV-16 E6–E7 promoter in keratinocytes. Virology. 399(2). 270–279. 24 indexed citations
5.
6.
7.
Lace, Michael J., James R. Anson, Aloysius J. Klingelhutz, et al.. (2009). Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis. 30(8). 1336–1344. 20 indexed citations
8.
9.
Lace, Michael J., James R. Anson, Aloysius J. Klingelhutz, et al.. (2009). Human Papillomavirus (HPV) Type 18 Induces Extended Growth in Primary Human Cervical, Tonsillar, or Foreskin Keratinocytes More Effectively than Other High-Risk Mucosal HPVs. Journal of Virology. 83(22). 11784–11794. 28 indexed citations
10.
Lace, Michael J., Christina Isacson, James R. Anson, et al.. (2009). Upstream Regulatory Region Alterations Found in Human Papillomavirus Type 16 (HPV-16) Isolates from Cervical Carcinomas Increase Transcription, ori Function, and HPV Immortalization Capacity in Culture. Journal of Virology. 83(15). 7457–7466. 45 indexed citations
11.
Lace, Michael J., James R. Anson, Gregory S. Thomas, Lubomír P. Turek, & Thomas H. Haugen. (2008). The E8 ∧ E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes. Journal of Virology. 82(21). 10841–10853. 63 indexed citations
12.
Lace, Michael J., James R. Anson, Lubomír P. Turek, & Thomas H. Haugen. (2008). Functional Mapping of the Human Papillomavirus Type 16 E1 Cistron. Journal of Virology. 82(21). 10724–10734. 28 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa C. Stoppler Breakdown of academic impact, for papers by Elke Beyer‐Finkler Breakdown of academic impact, for papers by Jordan M. Meyers Breakdown of academic impact, for papers by Meghan Hotz Breakdown of academic impact, for papers by Tara J. Nulton Breakdown of academic impact, for papers by Michaël Lehoux Breakdown of academic impact, for papers by Walter G. Hubert Breakdown of academic impact, for papers by Louis Cicchini Breakdown of academic impact, for papers by Valdimara Corrêa Vieira Breakdown of academic impact, for papers by Heike E. Brand
Rankless by CCL
2026